Get the Stockscreener App
0.6966
18.11%
0.1068
After Hours:
.70
0.0034
+0.49%
Cosmos Health Inc stock is traded at $0.6966, with a volume of 1.42M.
It is up +18.11% in the last 24 hours and up +60.14% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.5898
Open:
$0.562
24h Volume:
1.42M
Relative Volume:
3.07
Market Cap:
$20.03M
Revenue:
$56.04M
Net Income/Loss:
$-20.39M
P/E Ratio:
-0.2855
EPS:
-2.44
Net Cash Flow:
$-6.84M
1W Performance:
+58.21%
1M Performance:
+60.14%
6M Performance:
-11.10%
1Y Performance:
-45.58%
1-Day Range:
$0.5611
$0.72
1-Week Range:
$0.448
$0.72
52-Week Range:
$0.2801
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.6966 | 17.25M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
711.82 | 88.71B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
290.36 | 56.30B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
157.14 | 37.78B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
71.46 | 9.08B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
2.00 | 701.93M | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc Stock (COSM) Latest News
Is Cosmos Health Inc. a good long term investmentTriple returns potential - Autocar Professional
Cosmos Health Inc. (NASDAQ:COSM) Surges 34% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Why Cosmos Health Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Cosmos Health Inc. Stock Analysis and ForecastUnprecedented profit potential - Autocar Professional
What analysts say about Cosmos Health Inc. stockConsistently exceptional gains - jammulinksnews.com
What drives Cosmos Health Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com
Cosmos Health Insiders Placed Bullish Bets Worth US$1.63m - simplywall.st
What makes Cosmos Health Inc. stock price move sharplyFree Signals Group - Newser
How Cosmos Health Inc. stock performs during market volatilityInsider Level Guidance - Newser
Cosmos Health (NASDAQ:COSM) Trading 3.3% Higher – Here’s What Happened - Defense World
Cosmos Health enters U.S. market with DolCas Biotech agreement - Yahoo Finance
Cosmos Health (COSM) Enters U.S. Market with New Manufacturing Agreement | COSM Stock News - GuruFocus
Cosmos Health begins US manufacturing with DolCas Biotech By Investing.com - Investing.com India
Isaac GR00T N1: World’s first foundation model for humanoid robotics unveiled by NVIDIA - Interesting Engineering
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven - mx.advfn.com
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million - Revista ADVFN
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - The Globe and Mail
Cosmos Health CEO Grigorios Siokas acquires $15,216 in stock - Investing.com Australia
Cosmos Health CEO Grigorios Siokas acquires $15,216 in stock By Investing.com - Investing.com Canada
Cosmos health CEO acquires shares worth $82,000 By Investing.com - Investing.com South Africa
Cosmos health CEO acquires shares worth $82,000 - Investing.com Australia
Cosmos Health CEO Grigorios Siokas acquires $65,960 in stock By Investing.com - Investing.com South Africa
Cosmos Health CEO Grigorios Siokas acquires $65,960 in stock - Investing.com
Cosmos Health CEO Grigorios Siokas acquires shares in debt exchange By Investing.com - Investing.com Nigeria
Cosmos Health CEO Grigorios Siokas acquires shares in debt exchange - Investing.com
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.81%
1.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):